Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.49−0.50 (-2.78%)
Close on Nov 13, 2026Market cap $1.27BP/E –Yield –
Omeros cash
Cash and short-term investments held at the end of each period.
Omeros's cash was $131.95M at Jun 30, 2026. For fiscal 2025 it was $171.80M, up 90.7% from the year before. Over ten years it grew 19.8% a year on average. The highest annual figure on record is $194.90M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $171.80M | +90.7% |
| FY2024 | Dec 31, 2024 | $90.10M | -47.6% |
| FY2023 | Dec 31, 2023 | $171.80M | -11.9% |
| FY2022 | Dec 31, 2022 | $194.90M | +23.9% |
| FY2021 | Dec 31, 2021 | $157.30M | +16.6% |
| FY2020 | Dec 31, 2020 | $134.95M | +122.0% |
| FY2019 | Dec 31, 2019 | $60.80M | +0.5% |
| FY2018 | Dec 31, 2018 | $60.50M | -27.7% |
| FY2017 | Dec 31, 2017 | $83.70M | +84.8% |
| FY2016 | Dec 31, 2016 | $45.30M | +60.1% |
| FY2015 | Dec 31, 2015 | $28.30M | +310.1% |
| FY2014 | Dec 31, 2014 | $6.90M | -51.1% |
| FY2013 | Dec 31, 2013 | $14.10M | +827.6% |
| FY2012 | Dec 31, 2012 | $1.52M | -62.0% |
| FY2011 | Dec 31, 2011 | $4.01M | +22.2% |
| FY2010 | Dec 31, 2010 | $3.28M | +299.8% |
| FY2009 | Dec 31, 2009 | $820.00K | -93.6% |
| FY2008 | Dec 31, 2008 | $12.73M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $131.95M | +359.8% |
| Q1 FY2026 | Mar 31, 2026 | $135.32M | +158.2% |
| Q4 FY2025 | Dec 31, 2025 | $171.80M | +90.7% |
| Q3 FY2025 | Sep 30, 2025 | $36.10M | -70.7% |
| Q2 FY2025 | Jun 30, 2025 | $28.70M | -81.9% |
| Q1 FY2025 | Mar 31, 2025 | $52.40M | -77.2% |
| Q4 FY2024 | Dec 31, 2024 | $90.10M | -47.6% |
| Q3 FY2024 | Sep 30, 2024 | $123.20M | -60.3% |
| Q2 FY2024 | Jun 30, 2024 | $158.90M | -53.4% |
| Q1 FY2024 | Mar 31, 2024 | $230.30M | -38.0% |
| Q4 FY2023 | Dec 31, 2023 | $171.80M | -11.9% |
| Q3 FY2023 | Sep 30, 2023 | $310.30M | +40.4% |
| Q2 FY2023 | Jun 30, 2023 | $341.30M | +178.4% |
| Q1 FY2023 | Mar 31, 2023 | $371.40M | +161.2% |
| Q4 FY2022 | Dec 31, 2022 | $194.90M | +23.9% |
| Q3 FY2022 | Sep 30, 2022 | $221.00M | +338.5% |
| Q2 FY2022 | Jun 30, 2022 | $122.60M | +22.0% |
| Q1 FY2022 | Mar 31, 2022 | $142.20M | +5.4% |
| Q4 FY2021 | Dec 31, 2021 | $157.30M | +2.5% |
| Q3 FY2021 | Sep 30, 2021 | $50.40M | +213.0% |
| Q1 FY2021 | Mar 31, 2021 | $100.48M | +86.1% |
| Q4 FY2020 | Dec 31, 2020 | $134.95M | +122.0% |
| Q3 FY2020 | Sep 30, 2020 | $153.50M | +461.4% |
| Q2 FY2020 | Jun 30, 2020 | $16.10M | -49.4% |
| Q1 FY2020 | Mar 31, 2020 | $54.00M | +1232.0% |
| Q4 FY2019 | Dec 31, 2019 | $60.80M | +0.5% |
| Q3 FY2019 | Sep 30, 2019 | $27.34M | -50.5% |
| Q2 FY2019 | Jun 30, 2019 | $31.85M | -64.0% |
| Q1 FY2019 | Mar 31, 2019 | $4.05M | -94.4% |
| Q4 FY2018 | Dec 31, 2018 | $60.50M | -27.7% |
| Q3 FY2018 | Sep 30, 2018 | $55.20M | -36.4% |
| Q2 FY2018 | Jun 30, 2018 | $88.40M | +197.6% |
| Q1 FY2018 | Mar 31, 2018 | $72.80M | +116.0% |
| Q4 FY2017 | Dec 31, 2017 | $83.70M | +84.8% |
| Q3 FY2017 | Sep 30, 2017 | $86.80M | +83.1% |
| Q2 FY2017 | Jun 30, 2017 | $29.70M | +40.1% |
| Q1 FY2017 | Mar 31, 2017 | $33.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $45.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $47.40M | – |
| Q2 FY2016 | Jun 30, 2016 | $21.20M | – |
See a number that looks wrong?